Elsevier

Joint Bone Spine

Volume 70, Issue 6, December 2003, Pages 509-514
Joint Bone Spine

Original article
Evaluating changes in health status: sensitivity to change of the modified Arabic health assessment questionnaire in patients with rheumatoid arthritis

https://doi.org/10.1016/S1297-319X(03)00110-6Get rights and content

Abstract

Objective. – To test the correlation between clinical improvements in patients with rheumatoid arthritis (RA) as defined by the American College of Rheumatology (ACR) response criteria and functional improvements as assessed by functional measures in the modified Arabic version of the Health Assessment Questionnaire (Arabic-HAQ) and to estimate the sensitivity to change of the Arabic-HAQ, in a prospective study.

Methods. – Eighty-two patients with active RA were given methotrexate and followed up prospectively for 12 months. ACR response rates and score improvements on the modified Arabic-HAQ were compared.

Results. – The Arabic-HAQ scores showed significant sensitivity to change after 6 and 12 months and were significantly correlated with the ACR response. Percentages of agreement with ACR response levels were high after 6 months and higher still after 12 months. Standardized effect sizes were 2.34 and 2.84 after 6 and 12 months, respectively. Relative efficiency of the total Arabic-HAQ score in relation to the tender joint count was greater than 1.

Conclusion. – The Arabic-HAQ is valid and sensitive to functional status changes in patients with RA. The results are comparable to those of the original HAQ. Thus, the Arabic-HAQ can be used to evaluate treatments and to identify changes that are important to RA patients.

Introduction

Since the disability caused by rheumatoid arthritis (RA) exacts a heavy human and economic toll, the prevention of functional loss is a major therapeutic goal [1], [2]. The importance of preserving function was emphasized in 1985 when the World Health Organization defined a holistic approach to health involving assessments not only of disease activity but also of functional disability [3]. However, in the treatment of diseases such as RA that can interfere with daily activities, it is useful to identify the disease effects that are of greatest concern to the patient. These effects may differ from the clinical manifestations usually measured by clinicians [4]. Function as assessed by self-report questionnaires has been identified by the American College of Rheumatology (ACR) [5] and European groups as a “core set” parameter for disease activity measurement and is now routinely evaluated in randomized clinical trials [6], [7], [8]. Similarly, functional assessment by questionnaires has been strongly recommended for observational studies [9] and clinical practice [10].

By far the most widely used questionnaire is the Health Assessment Questionnaire (HAQ), a self-administered tool that has been found simple, easy to use, and reproducible [11], [12]. Several versions of the HAQ have been developed to take cultural variations into account, and the tool has been translated into Spanish, Swedish, French, Italian, Korean, Chinese, and Portuguese [13], [14], [15], [16], [17], [18], [19].

A modified version of the HAQ in Arabic (Arabic-HAQ) was developed recently [20]. Although this version has been proved reliable, valid, and reproducible, its sensitivity to change has not been evaluated. We, therefore, conducted a prospective study in RA patients to assess correlations between clinical improvements as defined by ACR response criteria and functional improvement as assessed by the Arabic-HAQ and to evaluate the sensitivity to change of the Arabic-HAQ as compared to changes in other disease parameters.

Section snippets

Patients

Eighty-two consecutive patients fulfilling 1987 ACR criteria for RA [21] were included in the study. There were 59 women and 23 men, recruited at the Rheumatology and Rehabilitation Outpatient Clinics of the Ain Shams University Hospital (Egypt, n = 44) and Saudi German Hospital (Saudi Arabia, n = 38) where they were being evaluated for newly diagnosed RA or for a flare occurring in the absence of second-line therapy. Baseline demographic data including a detailed history were recorded. The

Statistical analysis

The study data were reviewed, coded, tabulated, and entered into a PC for statistical analysis. Relative-change variables were created by calculating the percentage change in each disease activity parameter as the difference between the baseline value and the 6- or 12-month value divided by the baseline value of the same variable. The standardized effect size (SES) was calculated as the ratio of the mean difference over the standard deviation of the mean score change. Relative efficiency (RE)

Results

The 82 RA patients ranged in age from 21 to 72 years (mean, 45.6 ± 14.0 years). Median disease duration was 2 years (6 months–25 years) (Table 1). The patients were evaluated then included in the study at methotrexate initiation.

After 6 and 12 months on methotrexate therapy, improvements were noted in all disease activity parameters and all Arabic-HAQ items. The median total Arabic HAQ index decreased from 2.5 at baseline to 1.4 after 6 months and 0.53 after 12 months (Table 2).

The changes in

Discussion

The potential advantages of disease-specific functional status instruments over generic instruments include enhanced validity and clinical relevance, as well as greater sensitivity to change. The reliability and validity of a modified and translated Arabic version of the original HAQ were tested in RA patients in an earlier study [20]. The aim of the present study was to test the sensitivity to change of this Arabic-HAQ in a prospective study of RA patients.

Significant improvements in function

References (30)

  • Y.M El-Miedany et al.

    Is anxiety a more common disorder than depression in rheumatoid arthritis

    Joint Bone Spine

    (2002)
  • T Pincus et al.

    The side effects of rheumatoid arthritis: joint destruction, disability and early mortality

    Br J Rheumatol

    (1993)
  • S.H Allaire et al.

    The costs of rheumatoid arthritis

    Pharmacoeconomics

    (1994)
  • The first ten years of the World Health Organisation

    (1985)
  • J.F Fries et al.

    Measurement of patients outcome in arthritis

    Arthritis Rheum

    (1980)
  • D.T Felson et al.

    The American College of Rheumatology preliminary core set of disease activity measure for rheumatoid arthritis clinical trials. The Committee on outcome measures in rheumatoid arthritis clinical trials

    Arthritis Rheum

    (1993)
  • A.M Vangestel et al.

    ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials

    J Rheumatol

    (1999)
  • M Boers et al.

    WHO and ILAR core endpoints for symptom modifying antirheumatic drugs in RA clinical trials

    J Rheumatol

    (1994)
  • D.L Scott et al.

    Disease activity in rheumatoid arthritis—preliminary report of the consensus study group of the European workshop for rheumatology research

    Clin Exp Rheumatol

    (1992)
  • F Wolfe et al.

    Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology

    J Rheumatol

    (1999)
  • F Wolfe et al.

    Current comment—listening to the patient—a practical guide to self-report questionnaires in clinical care

    Arthritis Rheum

    (1999)
  • M.H Liang et al.

    In search of a more perfect mousetrap (health status or quality of life instrument)

    J Rheumatol

    (1982)
  • J.F Fries et al.

    The dimensions of health outcomes; the Health Assessment Questionnaire, disability and pain scales

    J Rheumatol

    (1982)
  • J Esteve-Vives et al.

    Grupo Para La Adaptacion Del HAQ a la poblacion Espanola. Spanish version of the Health Assessment Questionnaire: reliability, validity, and transcultural equivalency

    J Rheumatol

    (1993)
  • C Ekdahl et al.

    Assessing disability in patients with rheumatoid arthritis: use of a Swedish version of the Standard Health Assessment Questionnaire

    Scand J Rheumatol

    (1988)
  • Cited by (8)

    • Risk factors associated with bone loss and occurrence of fragility fractures in rheumatoid arthritis patients

      2019, Egyptian Rheumatologist
      Citation Excerpt :

      The joint destruction and severity were assessed using of the Sharp van der Heijde (SvdH) score [14]. The functional impact was evaluated by the health assessment questionairre (HAQ) score [15]. Dual-energy X-ray absorptiometry (DXA) was used to measure the BMD of the lumbar spine and the femoral neck.

    View all citing articles on Scopus
    View full text